We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+0.96%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$623M
AUM Growth
+$318M
Cap. Flow
-$181M
Cap. Flow %
-29%
Top 10 Hldgs %
75.39%
Holding
112
New
40
Increased
17
Reduced
5
Closed
34

Top Buys

Rank Stock Value
1
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$3.75M
2
MU icon
Micron Technology
MU
+$3.59M
3
ACOR
Acorda Therapeutics
ACOR
+$3.51M
4
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$749K
5
CWEI
Clayton Williams Energy, Inc.
CWEI
+$536K

Top Sells

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$2.85M
2
AEPI
AEP Industries Inc
AEPI
+$1.16M
3
STJ
St Jude Medical
STJ
+$962K
4
RAD
Rite Aid Corporation
RAD
+$958K
5
YDKN
Yadkin Financial Corporation
YDKN
+$685K

Sector Composition

Rank Sector Weight
1 Miscellaneous 95.54%
2 Healthcare 1.83%
3 Technology 0.9%
4 Consumer Staples 0.44%
5 Financials 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTK
1
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$20M 3.2%
1,035,800
+989,800
+2,152% +$15.6M
NXPI icon
2
CALL
NXP Semiconductors
NXPI
$56.4B
$18.5M 2.96%
+178,400
New +$18M
SAGE
3
CALL
DELISTED
Sage Therapeutics
SAGE
$17.5M 2.8%
+245,800
New +$14.4M
SAGE
4
PUT
DELISTED
Sage Therapeutics
SAGE
$15.7M 2.51%
+220,300
New +$12.9M
ANIP icon
5
PUT
ANI Pharmaceuticals
ANIP
$1.67B
$8.71M 1.4%
176,000
+135,000
+329% +$7.58M
SIOX
6
CALL
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$7.86M 1.26%
+65,838
New +$6.9M
SWC
7
PUT
DELISTED
Stillwater Mining Co
SWC
$7.01M 1.13%
+406,000
New +$6.94M
ZGNX
8
CALL
DELISTED
Zogenix, Inc.
ZGNX
$5.98M 0.96%
552,300
+447,900
+429% +$4.54M
ACOR
9
DELISTED
Acorda Therapeutics
ACOR
$5.92M 0.95%
2,349
+1,220
+108% +$3.51M
ACOR
10
PUT
DELISTED
Acorda Therapeutics
ACOR
$5.91M 0.95%
2,349
+288
+14% +$829K
INSM icon
11
PUT
Insmed
INSM
$25.9B
$5.78M 0.93%
+330,400
New +$5.1M
PRTK
12
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4.78M 0.77%
248,406
+238,116
+2,314% +$3.75M
DBVT
13
CALL
DBV Technologies
DBVT
$851M
$4.44M 0.71%
+12,610
New +$4.43M
MU icon
14
Micron Technology
MU
$1.05T
$4.25M 0.68%
+147,100
New +$3.59M
DBRG icon
15
PUT
DigitalBridge
DBRG
$2.99B
$2.98M 0.48%
+57,750
New +$3.25M
ZYNE
16
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$2.98M 0.48%
+148,400
New +$2.95M
FOMX
17
CALL
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$2.6M 0.42%
+523,900
New +$5.04M
ARAV
18
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
$2.33M 0.37%
+18,233
New +$1.92M
ZYNE
19
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$2.06M 0.33%
+102,400
New +$2.03M
PRTK
20
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.27M 0.2%
+66,100
New +$1.04M
RAI
21
DELISTED
Reynolds American Inc
RAI
$1.07M 0.17%
17,000
+2,000
+13% +$120K
BEAV
22
DELISTED
B/E Aerospace Inc
BEAV
$898K 0.14%
14,000
+4,000
+40% +$251K
RCKT icon
23
CALL
Rocket Pharmaceuticals
RCKT
$424M
$870K 0.14%
109,875
+23,075
+27% +$155K
IMDZ
24
CALL
DELISTED
Immune Design Corp.
IMDZ
$814K 0.13%
120,100
+99,200
+475% +$574K
IMMU
25
CALL
DELISTED
Immunomedics Inc
IMMU
$692K 0.11%
+107,200
New +$543K
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.51B AUM 33.02% 1-Year Est. Return
SC
Styrax Capital New York $1.52B AUM 57.44% 1-Year Est. Return
HCM
Hodges Capital Management Dallas, Texas $1.51B AUM 85.85% 1-Year Est. Return
NB
NBT Bank Norwich, New York $1.51B AUM 24.9% 1-Year Est. Return
WFA
Wellspring Financial Advisors Cleveland, Ohio $1.52B AUM 29.68% 1-Year Est. Return
APF
Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return
RIM
Rush Island Management New York $1.51B AUM 8.12% 1-Year Est. Return

DLD Asset Management's Q1 2017 Portfolio in Review

As of Q1 2017, DLD Asset Management held 112 positions worth $623M, up 104% from $305M the previous quarter. Its ten largest holdings account for 75% of the portfolio.

DLD Asset Management withdrew a net $181M in Q1 2017, closing 34 positions and reducing 5 holdings. Its most notable exit was Charter Communications, an estimated $2.85M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 96% of assets, up from 93% a quarter earlier, followed by Healthcare and Technology.

Against the trend, DLD Asset Management opened a new position in Micron Technology worth $4.25M.

  • DLD Asset Management's largest Q1 2017 buy was Micron Technology: 147,100 shares worth $4.25M.
  • DLD Asset Management added most to Paratek Pharmaceuticals, Inc. in Q1 2017, an estimated $3.75M increase.
  • DLD Asset Management's biggest Q1 2017 reduction was PrivateBancorp Inc, cutting an estimated $168K.
  • DLD Asset Management fully exited Charter Communications in Q1 2017, selling an estimated $2.85M.
  • DLD Asset Management's ten largest holdings make up 75% of its $623M portfolio in Q1 2017.
  • DLD Asset Management opened 40 new positions and closed 34 in Q1 2017.
  • DLD Asset Management's portfolio value rose 104% quarter-over-quarter to $623M.

Based on DLD Asset Management's 13F filing for Q1 2017, filed 12 May 2017.